Business Context and Reporting Period
This Form 8-K Current Report was filed by Aqua Metals, Inc. (Nasdaq: AQMS) on September 6, 2024, regarding an event that occurred on September 4, 2024. The filing addresses a corporate governance issue related to the company's continued listing on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a listing compliance matter and does not contain financial performance data.
Material Changes
The material change reported is the resignation of Edward Smith from the Board of Directors on August 21, 2024. Mr. Smith was a member of the audit committee. His departure reduced the number of independent directors eligible to serve on the audit committee below the required minimum of three, causing the company to fall out of compliance with Nasdaq Listing Rule 5605(c)(2).
Outlook, Risks, and Management Commentary
On September 4, 2024, the company received a letter from Nasdaq notifying it of the non-compliance. Under Nasdaq Listing Rule 5605(c)(4), the company has an automatic cure period to regain compliance. The deadline to evidence compliance is the earlier of the next annual stockholders' meeting or August 21, 2025 (or February 17, 2025, if the annual meeting is held before that date). Management intends to appoint a third independent director to the Board and audit committee to resolve the issue in a timely manner.
Investor Verification Checklist
- Verify the timeline for appointing a new independent director to the audit committee.
- Monitor subsequent filings to confirm the appointment of the new director before the cure period deadline.
- Review the company's most recent 10-K or 10-Q for financial health, as this 8-K contains no financial data.
- Check for any additional governance changes or board resignations that could impact compliance.